bioAffinity Technologies Stock (NASDAQ: BIAF) stock price, news, charts, stock research, profile.
Open | $2.75 |
Close | - |
Volume / Avg. | 136.78K / 97.01K |
Day Range | 2.70 - 2.97 |
52 Wk Range | 0.95 - 3.62 |
Market Cap | $33.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | 9.52% |
Days to Cover | 8.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of bioAffinity Technologies (NASDAQ:BIAF) through any online brokerage.
Other companies in bioAffinity Technologies’s space includes: NKGen Biotech (NASDAQ:NKGN), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX), Nanoviricides (AMEX:NNVC) and Bolt Biotherapeutics (NASDAQ:BOLT).
There is no analysis for bioAffinity Technologies.
bioAffinity Technologies has a consensus price target of $6.00.
The stock price for bioAffinity Technologies (NASDAQ: BIAF) is $2.7 last updated Today at July 24, 2024 at 9:06 AM EDT.
There are no upcoming dividends for bioAffinity Technologies.
bioAffinity Technologies’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for bioAffinity Technologies.
bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.